A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer

References

• KaufmannMvon MinckwitzGMamounasEPRecommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancerAnn Surg Oncol20121951508151622193884
   PubMed Web of Science ®Google Scholar
• van der HageJAvan de VeldeCJJulienJPTubiana-HulinMVanderveldenCDuchateauLPreoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902J Clin Oncol200119224224423711709566
   PubMed Web of Science ®Google Scholar
• de GrootSCharehbiliAvan LaarhovenHWInsulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01Breast Cancer Res2016181326738606
   PubMed Web of Science ®Google Scholar
• LiedtkeCMazouniCHessKRResponse to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerJ Clin Oncol20082681275128118250347
   PubMed Web of Science ®Google Scholar
• RastogiPAndersonSJBearHDPreoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27J Clin Oncol200826577878518258986
   PubMed Web of Science ®Google Scholar
• GuarneriVBroglioKKauSWPrognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factorsJ Clin Oncol20062471037104416505422
   PubMed Web of Science ®Google Scholar
• CortazarPZhangLUntchMPathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisLancet2014384993816417224529560
   PubMed Web of Science ®Google Scholar
• VymetalkovaVPardiniBRosaFPolymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patientsCarcinogenesis2017381283927803053
   PubMed Web of Science ®Google Scholar
• LiMMShaoYBLiuHXuBHeBXEffect of single nucleotide polymorphisms of RS1799937 located in WT1 gene on the pathlogical complete response to neoadjuvant chemotherapy in breast cancer patientsZhonghua Yi Xue Za Zhi2016964435593562 Chinese27916075
   PubMedGoogle Scholar
• Le MorvanVLitièreSLaroche-ClaryAIdentification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trialPharmacogenomics J2015151636824958282
   PubMed Web of Science ®Google Scholar
• MarméFWerftWWalterACD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerBreast Cancer Res Treat2012132381983121960110
   PubMed Web of Science ®Google Scholar
• GuWLiuJWangZLiuYWenSADRB2 polymorphisms and dyslipidemia risk in Chinese hypertensive patientsClin Exp Hypertens201739213914428287890
   PubMed Web of Science ®Google Scholar
• Jean-AlphonseFGWehbiVLChenJβ2-adrenergic receptor control of endosomal PTH receptor signaling via GβγNat Chem Biol201713325926128024151
   PubMed Web of Science ®Google Scholar
• KilpeläinenTOLakkaTALaaksonenDEInteraction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention StudyMetabolism200857342843618249219
   PubMed Web of Science ®Google Scholar
• SzendreiBGonzález-LamuñoDAmigoTInfluence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss interventionAppl Physiol Nutr Metab201641330731426888112
   PubMed Web of Science ®Google Scholar
• HuangXEHamajimaNSaitoTPossible association of beta2-and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancerBreast Cancer Res20013426426911434877
   PubMed Web of Science ®Google Scholar
• WangWCJuanAHPanebraALiggettSBMicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulationProc Natl Acad Sci USA2011108156246625121447718
   PubMed Web of Science ®Google Scholar
• GerettoMPullieroARosanoCZhabayevaDBersimbaevRIzzottiAResistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulatorsAm J Cancer Res2017761350137128670496
   PubMed Web of Science ®Google Scholar
• ZhouLXuSYinWWeekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II studyOncotarget2017845793057931429108309
   PubMedGoogle Scholar
• International HapMap ConsortiumThe International HapMap ProjectNature2003426696878979614685227
   PubMed Web of Science ®Google Scholar
• MachukiJOZhangHYHardingSESunHMolecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic valueActa Physiol20182222e12978
   Web of Science ®Google Scholar
• duYZhouLWangYAssociation of alpha2a and beta2 adrenoceptor expression with clinical outcome in breast cancerCurr Med Res Opin20143071337134424559182
   PubMed Web of Science ®Google Scholar
• XuYYaoLOuyangTp53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancerClin Cancer Res200511207328733316243804
   PubMed Web of Science ®Google Scholar
• MarméFWerftWBennerAFGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancerAnn Oncol20102181636164220147743
   PubMed Web of Science ®Google Scholar
• GréenHSöderkvistPRosenbergPHorvathGPetersonCmdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapyClin Cancer Res2006123 Pt 185485916467099
   PubMed Web of Science ®Google Scholar
• WuJLiSJiaWReduced Let-7a Is Associated with Chemoresistance in Primary Breast CancerPLoS One2015107e013364326218285
   PubMed Web of Science ®Google Scholar